Psychiatrists Absent from Cost-of-Care Discussions
the Psychiatry Advisor take:
Mental health services are tied with cancer as the third most expensive medical treatment in the United States, behind only heart conditions and trauma, according to researchers in JAMA Psychiatry.
Spending on psychiatric medications alone was $34 billion in 2005, surpassing expenditures on cancer drugs by $8 billion. Yet many mental health providers experience chronic underfunding for other mental health services.
Despite these issues, and growing concerns about the escalating costs of U.S. health care overall, psychiatrists remain largely absent from discussions about how to control spending.
Andres Barkil-Oteo, MD, MSc, of Yale School of Medicine, David A. Stern, MD, of New York Medical College, and Melissa R. Arbuckle, MD, PhD, of Columbia University Medical Center, discuss how front-line psychiatrists can become more involved in these efforts.
They address issues including lack of transparency about the actual cost of care, discomfort discussing treatment costs with patients and lack of incorporating cost considerations into medical training for upcoming generations of psychiatrists, as well as potential solutions to these problems.
Addressing the Cost of Health Care
Psychiatry Advisor Articles
- Early Detection Markers of Alzheimer's Disease Possibly Identified
- Transcranial Direct Current Stimulation Inferior to Escitalopram
- Illicit Cannabis Use Among Adults Up Due to Medical Marijuana Laws
- Memory Training Opportunities Exist for Patients With Schizophrenia
- APA: Medical Discrimination Based on Size Psychologically, Physically Harms Patients
- Criteria For Identification of Smartphone Addiction
- Bipolar Disorder: Childhood Trauma Modulates Impact on Amygdala, Hippocampus
- Psychiatric Evaluations: Questions on Suicide Need to Be Rephrased
- Subsequent Suicide Attempts May Be Reduced by Emergency Department Interventions
- Elevated Levels of Childhood Adversity in Patients with Fibromyalgia and Chronic Widespread Pain
- Prescription Opioid Misuse Remains a Persistent Problem
- Revised Treatment Guidelines for Pediatric Acute Onset Neuropsychiatric Syndrome
- Long-term Response to Prophylactic Mood Stabilizers in Bipolar Disorder
- Medically Supervised Withdrawal, an Option for Pregnant Women Addicted to Opioids
- Navigating the Thin Line Between Identification & Intimacy With Patients